医学
淋巴结
乳腺癌
激素疗法
队列
全身疗法
肿瘤科
队列研究
内科学
化疗
辅助化疗
辅助治疗
疾病
癌症
妇科
作者
Vivianne C. G. Tjan‐Heijnen,Maaike de Boer
出处
期刊:PubMed
日期:2009-10-01
卷期号:8 (42): 137-9
被引量:13
摘要
Even when a breast cancer patient has only minimal lymph node involvement, additional therapy is needed. If women are not treated with adjuvant systemic therapy like chemotherapy and/or hormonal therapy, disease-free survival is reduced by 10% at 5-year follow-up. These are the main results from the MIRROR study, a Dutch cohort study in which all hospitals from The Netherlands have participated. The results were recently published in the New England Journal of Medicine (de Boer, 2009). The study was supported by a grant from the Netherlands Organization for Health Research and Development (945-06-509).
科研通智能强力驱动
Strongly Powered by AbleSci AI